OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial
Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, et al.
Cancer Research Communications (2023) Vol. 4, Iss. 1, pp. 28-37
Open Access | Times Cited: 6
Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, et al.
Cancer Research Communications (2023) Vol. 4, Iss. 1, pp. 28-37
Open Access | Times Cited: 6
Showing 6 citing articles:
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial)
Thierry Lecomte, Bruno Giraudeau, Jean-Marc Phelip, et al.
Digestive and Liver Disease (2025)
Open Access
Thierry Lecomte, Bruno Giraudeau, Jean-Marc Phelip, et al.
Digestive and Liver Disease (2025)
Open Access
MTHFD2 marks pemetrexed resistance in pulmonary adenocarcinoma with EGFR wild type
Sha Yao, Omar Elakad, Xiaolin Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Sha Yao, Omar Elakad, Xiaolin Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
AI-Enhanced RAIN Protocol: A Systematic Approach to Optimize Drug Combinations for Rectal Neoplasm Treatment
Nasrin Dashti, Ali Akbar Kiaei, Mahnaz Boush, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Nasrin Dashti, Ali Akbar Kiaei, Mahnaz Boush, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The role of l-leucovorin uptake and metabolism in the modulation of 5-fluorouracil efficacy and antifolate toxicity
Godefridus J. Peters, Ietje Kathmann, Elisa Giovannetti, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Godefridus J. Peters, Ietje Kathmann, Elisa Giovannetti, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Increased potentiation of 5-fluorouracil induced thymidylate synthase inhibition by 5,10-methylenetetrahydrofolate (arfolitixorin) compared to leucovorin in patients with colorectal liver metastases; The Modelle-001 Trial
Helena Taflin, Elisabeth Odin, Göran Carlsson, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access
Helena Taflin, Elisabeth Odin, Göran Carlsson, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access
